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• 1 in 3 seniors dies with Alzheimer's or another dementia. it kills more than 
breast cancer and prostate cancer combined (Alzheimer’s	Association,	
2020).	
• Death rates for Alzheimer’s disease are increasing, unlike heart disease and 
cancer death rates that are on the decline (CDC, 2020)
• Although Alzheimer's disease is not a preventable condition there are 
modifiable risk factors 
• While there is greater understanding of the pathophysiology of Alzheimer’s 
disease, its causation has yet to be fully uncovered and it is likely to be 
multifactorial (Hope, 2020)





Alzheimer’s disease is a cause of dementia that affects older adults worldwide. The sixth leading cause of death 
among adults is Alzheimer’s and an estimated five million Americans aged 65 years and older are living with this 
disease (Centers for Disease and Prevention, 2020).  Alzheimer's is a progressive disorder that causes the brain 
cells to degenerate and die and is a continuous decline in thinking, behavioral and social skills that disrupts a 
person's ability to function independently (Mayo Clinic, 2018). There are certain risk factors including age and 
family history, but the cause of Alzheimer’s remains unknown.  While studies show certain treatments can delay 
the onset of Alzheimer’s there is no definitive cure.  
As a future nurse practitioner this disease process is important to understand as it is widely seen in 
healthcare settings. Alzheimer’s disease is very prevalent in the United States and as a healthcare worker 
that will be focusing on family practice, Alzheimer’s is a disease that needs to be fully understood to 
monitor for signs and appropriately diagnose a patient. Since there is currently no cure for the disease, 
staying up to date on research and how to potentially prolong the disease is essential. 
• Age
• Family history and genetics
• Sex
• Past head trauma
• Down Syndrome
• Mild cognitive impairment 
• Poor sleep patterns 
• Lifestyle choices
• Heart health




• Optimal blood pressure
• Optimal BMI
• Optimal cholesterol levels
• Treating anxiety and
depression
• Maintaining social activity
• Physical activity and 
exercise 
• Smoking cessation 
• Limiting alcohol intake





• Difficulty with self care and 
daily activities 
• Short shuffling steps
• Tendency to fall backwards
• Delusions





• Incontinence (Alzate, 2018 )
Alzheimer’s disease is the most common cause of dementia among older adults. Dementia is the loss of 
cognitive functioning including thinking, remembering, reasoning and behavioral abilities to such an 
extent that it interferes with a person’s daily life and activities (U.S. Department of Health & Human 
Services, 2019). The early stages of Alzheimer’s begin with mild cognitive impairment and progresses to 
severe cognitive decline.  There is currently no definitive treatment or cause of the disease. The 
destruction and death of nerve cells causes memory failure, personality changes, problems carrying out 
daily activities and other symptoms (Alzheimer’s Association, 2020).
Alzheimer’s disease is characterized by extracellular amyloid deposits predominantly composed of 
amyloid-b peptides, intracellular neurofibrillary tangles made of hyperphosphorylated, and abnormally 
phosphorylated Tau protein (Dong et al, 2018). Beta-amyloid is a leftover fragment of a larger protein 
and have a toxic effect on neurons and to disrupt cell-to-cell communication (Mayo Clinic, 2018). Tau 
proteins play a part in a neuron's internal support and transport system to carry nutrients and other 
essential materials. In Alzheimer's disease, tau proteins change shape and organize themselves into 
structures called neurofibrillary tangles. The tangles disrupt the transport system and are toxic to cells 
(Mayo Clinic, 2018). 
The brain in Alzheimer’s has moderate cortical atrophy, the frontal and temporal cortices often have 
enlarged sulcal spaces with atrophy of the gyri and as a result there is often enlargement of the frontal 
and temporal horns of the lateral ventricles (DeTure & Dickson, 2019). 
• The last stages of Alzheimer’s disease affect the brains function of physical activities and includes 
difficulty swallowing, balancing, and bowel/bladder control which can lead to aspiration, 
pneumonia, infection, falls, fractures, bedsores, dehydration, and malnutrition (Mayo Clinic, 2018). 
• There are  correlations between depression, sleep disturbance, and anxiety with eventual 
Alzheimer’s dementia development, both as individual factors as well as comorbid conditions 
(Burke, Cadet, Alcide, O’Driscoll & Maramaldi, 2018).
• While there is no cure for Alzheimer’s there are two types of medications used to treat cognitive 
symptoms:
1. Cholinesterase inhibitors which include Aricept, Exelon, and Razadyne are used for 
early  to moderate stages. These medications prevent the breakdown of 
acetylcholine which is a chemical messenger important for learning and memory, 
delay or slow symptoms and prescribed to treat symptoms related to memory, 
thinking, language, and judgment. 
2. Memantine (Namenda) regulate glutamate which is a chemical involved in 
information processing, storage, and retrieval. And helps improve mental function 
and ability to perform daily activities (Alzheimer’s Association, 2020). 
Since there is no cure of Alzheimer's disease, management of  the disease and 
symptoms is crucial. Nurses occupy a position of trust in society and are ideally placed 
to offer information and advice to those for whom they care (Hope, 2020). 
• Provide thorough assessments to screen for early signs of Alzheimer's 
• Screen and treat for depression and anxiety
• Provide support/family involvement
• Teach families appropriate strategies to manage behaviors of the Alzheimer 
patient to prevent caregiver burden (Delfino et al, 2019)
• Encourage regular exercise as a non-pharmacological intervention as it could 
potentially reduce the risk of dementia and have therapeutic potential in patient 
diagnosed with Alzheimer’s (Ströhle et al, 2015)
• Educate patient on modifiable risk factors including: diabetes, hypertension, 
obesity, high cholesterol, social isolation, lack of cognitive leisure activities, 
smoking, alcohol consumption, and poor diet (Hope, 2020)
• Prescribe appropriate medications for symptoms 
• In late stages of Alzheimer's be mindful that patient cannot communicate pain or 
discomfort; frequent check ups will be required (Alzheimer's Association, 2020)
• Maintain quality of life
(Verkhratsky, Parpura, Rodriguez-Arellano, & Zorec, 2019) 
(Trend Health, 2019)
(Osman, 2019)
